Details of the Drug

General Information of Drug (ID: DMMI258)

Drug Name

RG2077

Indication

Disease Entry	ICD 11	Status	REF
Graft-versus-host disease	4B24	Phase 1/2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT00094380) Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077). U.S. National Institutes of Health.